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Abstract
Background: In contrast to seasonal influenza epidemics, where the majority of deaths occur amongst elderly, a
considerable part of the 2009 pandemic influenza related deaths concerned relatively young people. In the
Netherlands, all deaths associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection had to be
notified, both during the 2009-2010 pandemic season and the 2010-2011 influenza season. To assess whether
and to what extent pandemic mortality patterns were reverting back to seasonal patterns, a retrospective
analyses of all notified fatal cases associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection
was performed.
Methods: The notification database, including detailed information about the clinical characteristics of all notified
deaths, was used to perform a comprehensive analysis of all deceased patients with a laboratory-confirmed
influenza A(H1N1) 2009 virus infection. Characteristics of the fatalities with respect to age and underlying medical
conditions were analysed, comparing the 2009-2010 pandemic and the 2010-2011 influenza season.
Results: A total of 65 fatalities with a laboratory-confirmed influenza A(H1N1) 2009 virus infection were notified in
2009-2010 and 38 in 2010-2011. During the pandemic season, the population mortality rates peaked in persons
aged 0-15 and 55-64 years. In the 2010-2011 influenza season, peaks in mortality were seen in persons aged 0-15
and 75-84 years. During the 2010-2011 influenza season, the height of first peak was lower compared to that
during the pandemic season. Underlying immunological disorders were more common in the pandemic season
compared to the 2010-2011 season (p = 0.02), and cardiovascular disorders were more common in the 2010-2011
season (p = 0.005).
Conclusions: The mortality pattern in the 2010-2011 influenza season still resembled the 2009-2010 pandemic
season with a peak in relatively young age groups, but concurrently a clear shift toward seasonal patterns was
seen, with a peak in mortality in the elderly, i.e. ≥ 75 years of age.
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In 2009, the rapid spread of an emerging influenza virus,
A(H1N1) of swine origin, resulted in the first pandemic
of the 21
st century [1]. This pandemic influenza A
(H1N1) 2009 virus has led to a limited outbreak in the
Netherlands with, as in many other countries, generally
mild illnesses in the majority of patients [2,3]. The pan-
demic was considerably less lethal than was expected,
with a low overall case fatality rate [4,5]. Nevertheless, a
considerable part of the pandemic influenza related
deaths concerned relatively young persons (mainly
young and middle aged adults) [3,5-8]. This is contrary
to seasonal influenza epidemics, where deaths occur
mainly amongst elderly aged 65 years or older [9-11].
In the Netherlands, all deaths associated with labora-
tory-confirmed influenza A(H1N1) 2009 virus infection
had to be notified since 30 April 2009. This mandatory
notification remained in place during the influenza sea-
son 2010-2011, which in Europe has been characterized
predominantly by the influenza A(H1N1) 2009 virus,
and to a lesser extent influenza virus type B [12,13].
The national notification system provided detailed
information of the clinical characteristics of all deaths
associated with a laboratory-confirmed influenza A
(H1N1) 2009 virus infection in the Netherlands. We
performed a retrospective analysis of all fatalities, com-
paring the 2009-2010 pandemic season with the 2010-
2011 influenza season, aiming to assess whether and to
what extent pandemic mortality patterns concerning age
distribution and underlying conditions were reverting to
seasonal patterns.
Methods
Data collection
In the Netherlands, laboratory investigation was indicated
for all hospitalised and/or deceased patients with sus-
pected influenza A(H1N1) 2009 virus during the 2009-
2010 pandemic as well as the 2010-2011 influenza sea-
son. Following laboratory confirmation of influenza A
(H1N1) 2009 virus infection, name and clinical character-
istics of hospitalised and deceased patients had to be
reported to the municipal health service (MHS) by both
the attending medical doctor and the head of the
involved microbiology laboratory. The MHS entered the
notifications into a national anonymous and password-
protected web-based database, including structured ques-
tions about patient demographics and information on
underlying medical conditions, treatments, clinical pre-
sentation, and admission to an intensive care unit (ICU).
In the pandemic season 2009-2010, additional informa-
tion on underlying conditions for deceased patients was
collected by the Centre for Infectious Disease Control
(CIb) of the National Institute for Public Health and the
Environment (RIVM) in consultation with the MHS and
subsequently added to the notification database.
Data analysis
The notification database was used to perform a com-
prehensive analysis of all deceased patients with a
laboratory-confirmed influenza A(H1N1) 2009 virus
infection. Ethical approval was not required for this
study as only anonymous data were used, and no (medi-
cal) interventions were made on human subjects.
Based on available clinical data, the underlying medical
conditions were classified into nine groups: no underly-
ing disorders, respiratory disorders, immunological disor-
ders (including haematological malignancies),
neurological disorders, intellectual disability (including
Down syndrome), cardiovascular disorders, kidney and/
or liver pathology, other non-specified malignancies and
metabolic disorders. Distinction was made between
patients with single and multiple underlying disorders.
Descriptive statistics were calculated for all available clin-
ical and epidemiological characteristics. Fisher’se x a c t
test was used to compare the 2009-2010 pandemic influ-
enza season (week 30 2009 - week 39 2010) and the
2010-2011 influenza season (week 40 2010 - week 39
2011) with respect to binary variables, and Wilcoxon-
Mann-Whitney test was used for continuous variables.
For both seasons, the pandemic influenza mortality rate
per 100, 000 persons was calculated as the number of
fatal pandemic influenza cases divided by the total Dutch
population (determined on 1 January 2009 and 2010) *
100, 000. For this analysis, the patients were categorised
in the following age groups:0-4, 5-14, 15-24, 25-34, ...,
75-84 and ≥ 85 years of age. All statistical analyses were
conducted using SAS version 9.2 (SAS Institute).
Results
A total of 103 fatalities with a laboratory-confirmed
influenza A(H1N1) 2009 virus infection were notified:
65 in the 2009-2010 pandemic season and 38 in 2010-
2011 influenza season. No pregnancy-related pandemic
influenza deaths were notified in either season. In 2009-
2010, 61 of the 65 patients (94%) were admitted to hos-
pital, 44 of them (68%) were admitted to the ICU, and
28 (43%) required mechanical ventilation because of
respiratory insufficiency. In 2010/2011, 37 of the 38
fatalities (97%) were admitted to hospital, 27 of them
(71%) to the ICU, and 23 (61%) required mechanical
ventilation. No statistical significant differences between
the two seasons were found for these variables.
Age distribution
The mean age of the deceased patients in 2009/2010
was lower compared to that in 2010/2011, respectively
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Page 2 of 541 and 53 years (p = 0.02). Figure 1 shows the mortality
rate per age group based on the total Dutch population
in 2009 and 2010. During the pandemic season, the
population mortality rates peaked in children aged
between 0 and 15 years of age and in persons aged
between 55 and 64 years. In the 2010-2011 influenza
season, the first peak was considerably lower, while the
second peak shifted to persons aged between 75 and 84
years.
Clinical presentation
Data on clinical presentation was available for 42 of the
65 fatalities (65%) during the pandemic seasons and for
28 of the 38 (74%) during the 2010-2011 season (table
1 ) .I nb o t hs e a s o n s ,f a t a lc a s e sp r e s e n t e dm a i n l yw i t h
respiratory symptoms (41%), including acute respiratory
distress syndrome (ARDS), followed by systemic symp-
toms (17%).
Immunological and respiratory disorders were the
most commonly reported underlying medical condi-
tions in the pandemic season, for respectively 23
(35%) and 22 (34%) of the 65 fatalities (table 2). In the
2010-2011 season, cardiovascular disorders and
absence of medical underlying conditions were most
common, respectively for 12 (32%) and 10 (26%) of
the 38 deaths. Underlying immunological disorders
were more common in the 2009-2010 compared to
the 2010-2011 season (p = 0.02), while cardiovascular
disorders were significantly more common in the
2010-2011 season (p = 0.005). Overall, multiple under-
lying conditions were reported for 27 of the 103 cases
(26%). Particularly, intellectual disability (100%), cardi-
ovascular (76%) and metabolic disorders (75%) were
found in combination with other underlying condi-
tions (data not shown).
Discussion
The peak in mortality rates in persons aged between 55
and 64 years observed during the 2009-2010 pandemic,
shifted to older age groups in the 2010-2011 influenza
season. Furthermore, the peak in mortality rates in chil-
dren younger than 15 years of age decreased
considerably.
The decline of the peak in children might partly be
explained by immunity in the youngest age groups, pos-
sibly related to high attack rates of influenza A(H1N1)
2009 virus in children during the pandemic season or to
persisting vaccine-induced immunity [14-16]. Although
Figure 1 Population mortality rates for laboratory-confirmed
influenza A(H1N1) 2009 virus infection per 100, 000 persons
for the pandemic season 2009-2010 and the following season
2010-2011.
Table 1 Clinical presentation reported for the deceased
patients with a laboratory-confirmed influenza A(H1N1)
2009 virus infection, the Netherlands 2009-2011 (n =
103)
Pandemic season
2009-2010
N=6 5
Influenza season
2010-2011
N=3 8
Clinical presentation n (%) n (%)
respiratory, including ARDS* 26 (40) 16 (42)
systemic 11 (17) 7 (18)
neurological 3 (5) 1 (3)
super infection 2 (3) 2 (5)
cardiovascular - 2 (5)
unknown 23 (35) 10 (26)
* ARDS = acute respiratory distress syndrome
Table 2 Underlying medical conditions of deceased
patients with a laboratory-confirmed influenza A(H1N1)
2009 virus infection, the Netherlands 2009-2011 (n =
103)
Pandemic
season
2009-2010
N=6 5
Influenza
season
2010-2011
N=3 8
Underlying medical condition* n (%) n (%) p
None** 10 (15) 10 (26) 0.3
Respiratory disorder 22 (34) 7 (18) 0.1
Immunological disorder
# 23 (35) 5 (13) 0.02
Neurological disorder 9 (14) 4 (10) 0.9
Intellectual disability
## 8 (12) 2 (5) 0.4
Cardiovascular disorders 5 (8) 12 (32) 0.005
Kidney/liver disorders 4 (6) 3 (8) 0.9
Malignancies
### 2 (3) 3 (8) 0.5
Metabolic disorders 1 (2) 3 (8) 0.3
Multiple underlying disorders 17 (26) 10 (26) > 0.9
* Patients with multiple underlying disorders are counted for every underlying
medical condition. For one patient underlying medical condition was
unknown.
** In one patient a group A streptococcal infection was confirmed after
autopsy.
# Including haematological malignancies.
## Including Down syndrome.
### Other non-specified malignancies.
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were very low in the older adults (≥ 40 years), the shift
of the peak in mortality rates towards older age groups
observed in our study might indicate increased circula-
tion of the virus in the 2010-2011 influenza season in
these age groups [14].
A shift of the age-specific mortality pattern similar to
that observed in our study is also described for the
post-pandemic seasons following the three pandemics in
the 20
th century. During each of these earlier pandemics,
persons younger then 65 years of age initially accounted
for a high proportion of influenza-related deaths, fol-
lowed by a declining proportion of deaths in the post-
pandemic seasons [17]. Simonsen et al. [17] hypothe-
sised that younger persons may retain long-lasting
immunity better than older persons after exposure to a
new influenza virus subtype.
Recent studies on risk factors for influenza A(H1N1)
2009 deaths concluded that the majority of severe pan-
demic cases as well as fatalities had underlying medical
conditions as previously also associated with severe sea-
sonal influenza [4,8,18-22]. Our results are in line with
previous studies in which respiratory disorders and
immunosuppressive conditions were frequently reported
as underlying diseases [4-6,18,21]. Furthermore, neuro-
logical disorders have been reported to be common
underlying diseases in fatal pandemic influenza cases,
especially in children and young adults [5,19]. Patients
with neurological and neuromuscular disease have also
been recognized as high-risk group for severe disease
from seasonal influenza [23].
Our study showed a noticeable number of deceased
patients (10%) with intellectual disability. Pérez-Padilla
et al. [24] recently showed that Down syndrome was
associated with adverse outcomes in cases of influenza-
like illness (ILI) and severe acute respiratory illness
(SARI) during the first months of the outbreak A
(H1N1) 2009 influenza virus. All intellectual disabled
patients in our study also had other chronic underlying
conditions, making it impossible to assess the specific
role of intellectual disability as a risk factor for fatal
influenza.
Although it has been reported that the A(H1N1) 2009
influenza virus caused severe illness and death in preg-
nant and postpartum women [25-27], as observed for
seasonal influenza, no pregnancy-related pandemic influ-
enza deaths were notified in the Netherlands. As we
noted for intellectual disorders, also for pregnancy fatal-
ities it is important to verify whether other chronic
underlying conditions are present.
The relatively high number of fatalities with underly-
ing cardiovascular disorders in the 2010-2011 influenza
season might be associated with the shift of the mortal-
ity rates to elderly persons, since cardiovascular
disorders are generally more common in elderly persons.
Because of the relatively small numbers of fatalities, it is
not possible to compare the differences in underlying
conditions between the two seasons adjusted by age.
There remains a possibility that fatal case ascertain-
ment is incomplete because of underreporting and
-diagnosing. Especially in patients with severe underly-
ing diseases and elderly, the generally non-specific
symptoms may not have been recognized as being
caused by influenza A(H1N1) 2009 virus infection.
This is reflected by the fact that pandemic influenza
was reported as contributing cause of death in some
patients instead of the main cause of death. Moreover,
this might also partly explain the relatively high mor-
tality in patients with underlying immunological disor-
ders in the 2009-2010 pandemic season compared to
the 2010-2011 influenza season. It is plausible that
testing for influenza was more common during the
pandemic season because of heightened attention, par-
ticularly in patients with severe underlying diseases
like immunological disorders.
To improve completeness of reporting in the hectic
pandemic season, additional information on underlying
conditions was actively collected where not available,
which might have caused some information bias.
Another limitation of this study is the lack of reliable
historical records on deaths related to laboratory-con-
firmed influenza. Although deaths associated with
laboratory-confirmed A(H1N1) 2009 virus infection
were notifiable during the 2009-2010 and 2010-2011
seasons, clinical influenza diagnoses are generally not
laboratory-confirmed during seasonal influenza epi-
demics. Nevertheless, estimates of the burden of seaso-
nal influenza show that about 90% of influenza-
associated deaths occur in persons aged 65 years and
older [9]. This is obviously different from the age speci-
fic mortality pattern seen during the 2009 and previous
pandemics.
Conclusions
The maintenance of the mandatory notification of
deaths associated with laboratory-confirmed influenza A
(H1N1) 2009 made it possible to compare the fatal
cases during the 2009-2010 pandemic season with that
during the 2010-2011 influenza season. The mortality
pattern in the 2010-2011 season still resembles the pan-
demic season with a peak in relatively young age groups,
but concurrently shows a clear shift towards the seaso-
nal pattern, as also described for previous pandemics in
the 20
th century.
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